ABX · Abacus Global Management, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Research
our published analysis of this company
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Annualized ROE non-GAAP | 22% | Six Months Ended June 30, 2026 | — |
| Adjusted Annualized ROIC non-GAAP | 20% | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA non-GAAP | $72,596,972 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA Margin non-GAAP | 54.8% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted EPS (Gross) non-GAAP | $0.28 | 2Q26 | — |
| Adjusted Net Income non-GAAP | $39,497,137 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted net income (Gross) non-GAAP | 27.1M | 2Q26 | — |
| Annualized ROE non-GAAP | 25% | 2Q26 | — |
|
|
|||
| Annualized ROIC non-GAAP | 23% | 2Q26 | — |
|
|
|||
| Average realized gain | 25% | 2Q26 | — |
|
|
|||
| Capital inflows | 256.1M | 2Q26 | — |
| Longevity funds new capital raised | 544.2M | First-Half 2026 | — |
| Annualized turnover ratio | 1.9 | 1Q26 | — |
| Gross AUM | 3.6B | 1Q26 | — |
| Gross capital inflows | 378M | 1Q26 | — |
| Longevity Income Funds AUM | 1B | 1Q26 | — |
| Operating Cash Flow | 91.7M | 1Q26 | — |
| Origination capital deployment | 163.6M | 1Q26 | — |
|
|
|||
| Asset base | $3.6B | fourth quarter of 2025 | — |
| Number of policy originations | 1,310 | full year 2025 | — |
| Originations capital deployment | $580.8M | full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ABX
this stock
Abacus Global Management, Inc.
|
$895.78M | +7.1% | +110.2% | 33.9 | 5.7% |
|
CILJF
China Life Insurance Co Ltd
|
$97.80B | -1.0% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$72.16B | +17.1% | — | — | 0.8% |
|
MET
Metlife Inc
|
$60.44B | +18.4% | +8.6% | 18.2 | 1.8% |
|
GWLIF
Great-West Lifeco Inc.
|
$58.30B | +29.3% | — | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ABX | +7.5% | -8.9% | +0.3% | -11.2% | +7.1% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +9.5% | -12.2% | -10.8% | -13.2% | -4.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.